Upgrade to SI Premium - Free Trial

Allergen (AGN) PT Raised to $189 at UBS

September 12, 2019 6:02 AM
UBS analyst Navin Jacob raised the price target on Allergen (NYSE: AGN) to $189.00 (from $172.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change